Assessment of clinical trial inclusion criteria to a cohort of lymphoma patients undergoing autologous transplantation: Are trial results generalized to other patient populations?

被引:0
|
作者
Kanjeekal, SM
Kouroukis, C
Henderson, N
Marcellus, D
Benger, A
Foley, R
Ingram, C
Meyer, RM
机构
[1] Hamilton Reg Canc Ctr, Hamilton, ON L8V 1C3, Canada
[2] Hamilton Hlth Sci Corp, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
570
引用
收藏
页码:132A / 132A
页数:1
相关论文
共 50 条
  • [41] AN ASSESSMENT OF THE IMPACT OF DISEASE ACTIVITY CRITERIA ON DOSING INTERVAL ASSIGNMENT IN CLINICAL TRIAL PATIENTS WITH NAMD
    Ghanchi, Faruque
    Weng, Christina Y.
    Souverain, Audrey
    Stoilov, Ivaylo
    Margaron, Philippe
    EYE, 2024, 38 : 200 - 200
  • [42] Autologous bone marrow transplantation versus conventional chemotherapy in patients with relapsed diffuse nonHodgkin's lymphoma. Results from a prospective, randomized phase III clinical trial in 216 patients (the Parma study).
    Hagenbeek, A
    Guglielmi, C
    Chauvin, F
    vanderLely, J
    Bron, D
    Sonneveld, P
    Gisselbrecht, C
    Cahn, JY
    Harousseau, JL
    Coiffier, B
    Biron, P
    Somers, R
    Philip, T
    BLOOD, 1995, 86 (10) : 1817 - 1817
  • [43] Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial.
    Schmitz, Norbert
    Nickelsen, Maike
    Altmann, Bettina
    Ziepert, Marita
    Bouabdallah, Kamal
    Gisselbrecht, Christian
    Maury, Sebastien
    Cartron, Guillaume
    Gyan, Emmanuel
    Jaccard, Arnaud
    Sanhes, Laurence
    Gaulard, Philippe
    Rosenwald, Andreas
    Truemper, Lorenz
    Glass, Bertram
    Reimer, Peter
    Herr, Wolfgang
    Wilhelm, Martin
    Tournilhac, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
    Schmitz, N
    Linch, DC
    Dreger, P
    Goldstone, AH
    Boogaerts, MA
    Ferrant, A
    Demuynck, HMS
    Link, H
    Zander, A
    Barge, A
    Borkett, K
    LANCET, 1996, 347 (8998): : 353 - 357
  • [45] A prospective randomised clinical trial with erythropoietin-alfa in patients undergoing unrelated stem cell transplantation
    Fauser, AA
    Kraut, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S55 - S55
  • [46] Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation:: results of a prospective study
    Díez-Campelo, M
    Pérez-Simón, JA
    González-Porras, JR
    García-Cecilia, JM
    Salinero, M
    Caballero, MD
    Cañizo, MC
    Ocio, EM
    San Miguel, JF
    BONE MARROW TRANSPLANTATION, 2004, 34 (08) : 729 - 738
  • [47] Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study
    M Díez-Campelo
    J A Pérez-Simón
    J R González-Porras
    J M García-Cecilia
    M Salinero
    M D Caballero
    M C Cañizo
    E M Ocio
    J F San Miguel
    Bone Marrow Transplantation, 2004, 34 : 729 - 738
  • [48] Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation
    Freytes, CO
    Ratanatharathorn, V
    Taylor, C
    Abboud, C
    Chesser, N
    Restrepo, A
    Arango, J
    Odenheimer, D
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8318 - 8324
  • [49] TOO STRINGENT PATIENT SELECTION CRITERIA IN A CLINICAL-TRIAL OF ALPHA-BLOCKERS REDUCE THE VALUE OF THE RESULTS
    ROSENBAUM, TP
    SHAW, PJR
    EUROPEAN UROLOGY, 1991, 20 (03) : 175 - 178
  • [50] Autologous transplantation for aggressive non-hodgkin's lymphoma: Results of a randomized trial evaluating graft source and minimal residual disease
    Vose, JM
    Sharp, G
    Chan, WC
    Nichols, C
    Loh, K
    Inwards, D
    Rifkin, R
    Bierman, PJ
    Lynch, JC
    Weisenburger, DD
    Kessinger, A
    Armitage, JO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) : 2344 - 2352